Azenta Inc (AZTA) - Financial and Strategic SWOT Analysis Review

Azenta Inc (AZTA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by the publisher to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

Business description - A detailed description of the company's operations and business divisions
Corporate strategy - Analyst's summarization of the company's business strategy
SWOT Analysis - A detailed analysis of the company's strengths, weakness, opportunities and threats
Company history - Progression of key events associated with the company
Major products and services - A list of major products, services and brands of the company
Key competitors - A list of key competitors to the company
Key employees - A list of the key executives of the company
Executive biographies - A brief summary of the executives' employment history
Key operational heads - A list of personnel heading key departments/functions
Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company
Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history
Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history

Highlights

Azenta Inc (Azenta), formerly Brooks Automation Inc, is a provider of sample exploration and management solutions for the life sciences market. The company's portfolio includes automated cold storage systems, cryogenic storage systems, and consumables and instruments such as racks, tubes, cups, plates, and foils. Azenta also offers a comprehensive suite of informatics for planning, data management, virtualization, visualization, scheduling laboratory workflow, sampling inventory and logistics, monitoring environmental and temperature, and management of clinical trial and consent. The company's service offerings include component exchange, repair, spare parts, and upgrades. It has operations in Europe, Asia-Pacific, and North America. Azenta is headquartered in Chelmsford, Massachusetts, the US.

Azenta Inc Key Recent Developments

Feb 08, 2023: Azenta Reports First Quarter Results For Fiscal 2023, Ended December 31, 2022
Nov 14, 2022: Azenta Announces Nomination of Tina S. Nova, Ph.D. and Dorothy E. Puhy to Board of Directors
Nov 14, 2022: Azenta Reports Fourth Quarter and Full Year Fiscal 2022 Results, Authorizes $1.5 Billion Share Repurchase Program
Nov 08, 2022: Azenta and the Government of Luxembourg announce a Memorandum of Understanding to facilitate continued healthcare technology development in Luxembourg

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers

The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company

The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably

Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance

Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios

Gain key insights into the company for academic or business research

Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs

Note: Some sections may be missing if data is unavailable for the company

Section 1 - About the Company

Azenta Inc - Key Facts
Azenta Inc - Key Employees
Azenta Inc - Key Employee Biographies
Azenta Inc - Major Products and Services
Azenta Inc - History
Azenta Inc - Company Statement
Azenta Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

Section 2 - Company Analysis

Company Overview
Azenta Inc - Business Description
Business Segment: Life Sciences Products
Overview
Performance
Business Segment: Life Sciences Services
Overview
Performance
Geographical Segment: Asia/Pacific/Other
Performance
Geographical Segment: China
Performance
Geographical Segment: Europe
Performance
Geographical Segment: North America
Performance
R&D Overview
Azenta Inc - SWOT Analysis
SWOT Analysis - Overview
Azenta Inc - Strengths
Azenta Inc - Weaknesses
Azenta Inc - Opportunities
Azenta Inc - Threats
Azenta Inc - Key Competitors

Section 3 - Company Financial Ratios

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

Section 4 - Company’s Lifesciences Financial Deals and Alliances

Azenta Inc, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
Azenta Inc, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023
Azenta Inc, Recent Deals Summary

Section 5 - Company’s Recent Developments

Feb 08, 2023: Azenta Reports First Quarter Results For Fiscal 2023, Ended December 31, 2022
Nov 14, 2022: Azenta Announces Nomination of Tina S. Nova, Ph.D. and Dorothy E. Puhy to Board of Directors
Nov 14, 2022: Azenta Reports Fourth Quarter and Full Year Fiscal 2022 Results, Authorizes $1.5 Billion Share Repurchase Program
Nov 08, 2022: Azenta and the Government of Luxembourg announce a Memorandum of Understanding to facilitate continued healthcare technology development in Luxembourg
Nov 07, 2022: Azenta Announces Fiscal 2022 Fourth Quarter and Full Year Earnings Conference Call and Webcast
Aug 09, 2022: Azenta agrees to purchase B Medical Systems for $469m

Section 6 - Appendix